Method for aiding implantation or decreasing miscarriage rate
AssigneeLaboratoires Seronosa
InventorYves Menezo
Life of this patent
Estimating the term…
Abstract
The invention provides a protocol leading to improved embryo implantation rates and/or decreased miscarriage rates in which hCG or LH, or a bio-analogue thereof, is administered during the follicular phase.
Claims6
A method for aiding/encouraging implantation and/or decreasing miscarriage rates of an embryo in a human patient, comprising administering human luteinising hormone (hLH) during controlled ovarian hyperstimulation (COH) in a human patient in need thereof, while continuing administration of FSH, wherein the hLH is administered starting between the 3rd and 10th day after commencing treatment with FSH, to aid/encourage implantation and/or decrease miscarriage rates of an embryo in the human patient.
Dependencies are inferred from the claim text.